Figure 3.
The survival analysis of Argonaute 1 and Argonaute 2. Patients with higher Argonaute 1 and Argonaute 2 expression in tumor tissue were closely correlated with poorer overall survival than patients with tumor with lower expression (p=0.040, p=0.038, respectively).